Vireo Growth Past Earnings Performance

Past criteria checks 0/6

Vireo Growth has been growing earnings at an average annual rate of 13.6%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 22.3% per year.

Key information

13.6%

Earnings growth rate

28.5%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate22.3%
Return on equityn/a
Net Margin-17.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Vireo Growth makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:VREO.F Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2499-17290
30 Jun 2498-17280
31 Mar 2493-24310
31 Dec 2388-26320
30 Sep 2383-34330
30 Jun 2377-37360
31 Mar 2378-36350
31 Dec 2275-42370
30 Sep 2269-43390
30 Jun 2264-41390
31 Mar 2257-41390
31 Dec 2154-34390
30 Sep 2153-22360
30 Jun 2152-13340
31 Mar 2150-22400
31 Dec 2049-23390
30 Sep 2048-63440
30 Jun 2042-78450
31 Mar 2036-62350
31 Dec 1930-57280
30 Sep 1925-17200
30 Jun 1922-4150
31 Mar 1921-4120
31 Dec 1818-3120
30 Sep 1816-290
31 Dec 1711060
31 Dec 164640

Quality Earnings: VREO.F is currently unprofitable.

Growing Profit Margin: VREO.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VREO.F is unprofitable, but has reduced losses over the past 5 years at a rate of 13.6% per year.

Accelerating Growth: Unable to compare VREO.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VREO.F is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (42%).


Return on Equity

High ROE: VREO.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 11:59
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vireo Growth Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matt BottomleyCanaccord Genuity
Eric Des LauriersCraig-Hallum Capital Group LLC
Graeme KreindlerEight Capital